Related Experiment Videos
Perimenopausal obesity
A Milewicz1, B Bidzińska, A Sidorowicz
1Department of Endocrinology, Medical University of Wrocław, Poland.
Summary
Perimenopausal obesity affects many women and is influenced by genetics, hormones, and the nervous system. Understanding these factors is key to developing effective treatments for this common condition.
Area of Science:
- Endocrinology
- Reproductive Medicine
- Obesity Research
Background:
- Perimenopausal obesity is a prevalent condition affecting up to 60% of women during menopause.
- Obesity carries severe clinical implications, necessitating research into its causes and treatments.
Purpose of the Study:
- To investigate the etiological factors contributing to perimenopausal obesity.
- To explore potential treatment strategies for perimenopausal obesity.
Main Methods:
- Review of existing literature on factors influencing perimenopausal obesity.
- Analysis of the roles of genetic factors, neuropeptides, adrenergic nervous system activity, and hormones.
Main Results:
- Multiple factors contribute to perimenopausal obesity, including genetics, neuropeptides, and hormonal changes.
- Reproductive hormones influence adipose tissue indirectly due to the absence of sex steroid receptors in fatty tissue.
- The role of hormone replacement therapy in perimenopausal obesity etiology requires further consideration.
Conclusions:
- Perimenopausal obesity is multifactorial, involving genetic, neural, and hormonal pathways.
- While reproductive hormones have an indirect effect, their role and that of hormone replacement therapy warrant continued investigation.
- Further research is needed to clarify the benefits of treatments for women experiencing menopausal age-related obesity.